🇺🇸 FDA
Pipeline program

Divalproex Sodium Extended-release 250mg

RIHSC #13-019D

Phase 1 small_molecule active

Quick answer

Divalproex Sodium Extended-release 250mg for Epilepsy is a Phase 1 program (small_molecule) at BRIGHT MINDS BIOSCIENCES INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
BRIGHT MINDS BIOSCIENCES INC.
Indication
Epilepsy
Phase
Phase 1
Modality
small_molecule
Status
active

Clinical trials